Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Revival Gold Marks Progress With Technical Programs
-
Plato Gold Welcomes the Honourable Andrew Leslie as Advisor to Plato Gold
-
Alaska Energy Metals to Explore Natural Hydrogen Resource Potential at the Angliers-Belleterre Project, Quebec, Canada
-
Prime Drink Group Raises an Additional $2.2 Million and Provides an Update on the Triani Acquisition
-
Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day
-
Amesite Releases 2025 Home Health Care Outlook, Offering Transformative AI Solutions that Every Company Needs
-
Angus Gold Successfully Targets High-grade Gold in BIF-Hosted Gold System; Intersects 5.4 g/t Au over 3.0 metres and 6.0 g/t Au over 1.8 metres, within broader envelope of 111 metres grading 1.0 g/t
-
Conavi Medical Corp. Commences Trading on TSX-V Under Symbol “CNVI”
-
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024
-
Vienna Insurance Group Subscribes to Intermap’s Real Estate Solution
-
SANUWAVE Health Announces 1-For-375 Reverse Stock Split
-
ElevateBio Announces Advancements of its Proprietary Lipid Nanoparticle (LNP) Delivery Platform with Liver Targeting and De-Targeting Potential
-
Brixton Metals Drills 8.00m of 11.37 g/t Gold including 2.00m of 44.43 g/t Gold all within 82.00m of 1.27 g/t Gold at its Trapper Target on the Thorn Project
-
XYZ Media Spotlights Tina Jin’s Affordable Water Filtration System Using Cow Bone Waste in ‘Next Generation of Innovators’ Series
-
Form 8.3 - MUSICMAGPIE PLC
-
Form 8.3 - TRINITY EXPLORATION & PRODUCTION PLC
-
JCS Solutions CEO Selected as a Cyber50 Executive for the First Time
-
ShorePoint Named a Cyber50 GovCon Honoree for Second Year Running
-
Enthusiast’s Luminosity Hosts Invitational Smash Bros Event for over 400,000 Unique Online Viewers
-
Lifeist Announces Conclusion of Consulting Agreement with Singular Narrative Management Ltd.
-
MADD Canada and MPI Deliver Sober Driving Message to Manitoba Students
-
Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024
-
Emerita Intersects 6.5m of Massive Sulfide Grading 1.1% Copper, 1.1% Lead, 3.1% Zinc, 73.35 g/t Silver And 1.36 g/t Gold at El Cura Deposit, Demonstrating Continuity of Mineralization Along Strike
-
Revolutionizing Lighting: Superior LED Technologies Unveils Industry's Most Efficient Lights, Setting a New Standard
-
Serve Robotics Rolls Out Third-Generation Autonomous Delivery Robot; Platform Upgrade Will Support National Scaling
-
POET Wins “Best in Artificial Intelligence” Honors at 2024 Global Tech Awards
-
Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by w
-
REPEAT - Court challenge to be heard Thursday re. Ford Government’s expansion & new 30-yr license for Southbridge’s Orchard Villa, for-profit long-term care with reprehensible record
-
2024 ASDSA Top Advocates Chosen
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
The Devon Group Launches the Clear Communicator Awards to Celebrate Excellence in HR Tech Marketing
-
Opthea Files Notice of Annual General Meeting
-
ASDSA Recognizes 2024 Patient Safety Hero Award Honorees
-
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
-
Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
-
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
-
Revolutionizing Lighting: Superior LED Technologies Unveils Industry's Most Efficient Lights, Setting a New Standard
-
Mesa Air Group Reports Third Quarter Fiscal 2024 Results
-
ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease
-
Sagimet Biosciences Announces Upcoming Presentations at AASLD - The Liver Meeting® 2024
-
Hydreight Provides Corporate Update Reflecting Significant Growth
-
Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
-
Barrick Reports Q3 Preliminary Production Results With Continued Improvement at Pueblo Viejo
-
Apellis Announces Oral Presentation at American Society of Nephrology (ASN) Kidney Week on Phase 3 VALIANT Study of Pegcetacoplan in C3G and Primary IC-MPGN
-
Tilray Announces Fall Craft Beer Lineup
-
New York Supreme Court Rules in Favor of Gyrodyne in Article 78 Proceeding
-
Revving Vive’s Highest Velocity Commercialization Engine
-
Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus
-
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
-
ICPO Foundation funded global “Radiopharmaceutical Trial Finder” developed by WARMTH and Ancora.ai
